Lists of pharmaceutical and life-science companies, with GMP context.

01  The market

Who this list is for

This page is for suppliers that sell to pharmaceutical and life-science companies: process and cleanroom equipment, single-use and bioprocessing systems, laboratory instruments and consumables, primary packaging, cold-chain logistics, validation, QA and regulatory services, and pharma engineering. In a regulated market a wrong first call costs credibility, so it matters whether a site makes sterile products, APIs or devices, and whether it develops or only manufactures.

What is in the list

The Pharma & Life Sciences unit covers 56 sub-sectors, from branded and generic manufacturers, API and intermediate producers, sterile and aseptic manufacturing, biologics and vaccines, cell and gene therapy, CDMOs, CMOs and CROs, to analytical labs, contract packaging, medical devices, in-vitro diagnostics, laboratory instrumentation and pharmaceutical wholesalers.

Every row has the company name, country, region, city, sector, sub-sector, company size, a priority rating and one sentence explaining why the company is a probable buyer of what you sell. You get an Excel file with filters on every column, usually within 5 minutes to 1 hour after payment confirmation on working days (orders at the weekend arrive on Monday; in exceptional cases up to 24 hours). We do not pad lists to reach a number, and we leave out your competitors.

A reason to contact every company

Each row explains why the company fits, for example the dosage forms or production steps that use your equipment, or a contract manufacturer whose service range matches your consumables. That gives your team a relevant first question and helps them avoid companies that only distribute or only do research.

Pharmaceutical companies in Switzerland

According to the Swiss Federal Department of Foreign Affairs, the chemical and pharmaceutical industry generates about half of Swiss exports, employs more than 75,000 people and counts roughly 1,000 operators, mainly around Basel, Zurich, Zug and Lake Geneva. Chemicals and pharma make up 44.9% of Basel-Stadt's value added (2022). Read our page on pharmaceutical companies in Switzerland or the Switzerland prospect lists.

Pharmaceutical companies in Germany

Destatis counts 134,195 people in 381 German pharmaceutical establishments (20 or more employees, end of September 2025). Baden-Württemberg (30,660), Hesse (26,221) and North Rhine-Westphalia (19,426) together hold 57% of them. See our Germany prospect lists.

Pharma companies in Denmark and Sweden

Statistics Denmark counts 42,868 people working in Danish pharma, 35,915 of them in the Capital Region and 4,918 in Kalundborg. Pharmaceuticals were SEK 152.7 billion of Swedish goods exports in 2025, and Vinnova counts 53,284 people in Swedish life-science companies (2023). See Denmark prospect lists and Sweden prospect lists.

Pharma and life sciences in Belgium and the Netherlands

Belgium's chemicals, plastics and life-sciences sector accounted for 32.1% of exports in 2025; the Walloon health cluster BioWin has more than 250 members. In the Netherlands, Leiden Bio Science Park hosts 519 organisations and more than 26,000 professionals, and Pivot Park in Oss more than 60 life-science companies, including contract manufacturers and CROs. See Belgium prospect lists and Netherlands prospect lists.

Pharma companies in France, the UK, Ireland and Austria

Urssaf data show 87,833 pharma jobs in metropolitan France, led by Auvergne-Rhône-Alpes (18,762) and Île-de-France (16,615). The ONS counts 41,000 pharma jobs in Great Britain, 10,000 of them in the North West. The CSO counts 33,783 people engaged in Irish pharma, led by Cork and Dublin. Austria has 21,973 people in 139 pharma establishments, mostly in Vienna and Tyrol. See France prospect lists, United Kingdom prospect lists, Ireland prospect lists and Austria prospect lists.

Figures are quoted from the official statistics and sector bodies cited on each linked country page, with their year. Nexfield does not publish company counts of its own.

Start with a €99 test

You do not have to commit to a full list to find out whether it works for selling into pharma. The Test is a sample of the real list: about 8 to 12 highly matched companies in one country, for example CDMOs in Switzerland or sterile manufacturers in Germany, delivered in the same Excel format as a full order. It costs €99, excluding VAT. One fixed price, no subscription, no contract, no minimum. If the sample fits, order Local (€950) for the rest of that country, or Regional (€1,500, two countries) and Regional Plus (€2,000, three countries) for a wider market.

Start with a €99 test or order a full list.

GDPR and company data

Every entry is researched by our AI and confirmed in public sources. The lists are about companies, not people: they contain no personal contact details and no email addresses, so you are not buying a database of individuals. You remain responsible for how you contact the companies, as set out in section 8 of our terms and conditions. Many customers add contacts afterwards with a tool such as Apollo or Lusha, once they know which companies are worth it.

02b  Specialist signals

Signals we look for

The signals this unit looks for:

• GMP certificates and new sites. New or renewed GMP certificates in the EU's public EudraGMDP database point to new capacity.
• Clinical phase transitions. A move to a later trial phase means scale-up, tech transfer and CDMO decisions.
• Sterile manufacturing upgrades. Since the revised EU GMP Annex 1 became fully applicable in August 2024, sterile sites keep investing in contamination control.

We speak your buyers' language

GMP, tech transfer, scale-up, validation, batch release, CMC, Annex 1, contamination control strategy.

Our method

Public, company-level sources only. The reason to contact names the signal we found, and we never invent one.